336 related articles for article (PubMed ID: 21351141)
1. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.
Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS
J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141
[TBL] [Abstract][Full Text] [Related]
2. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.
Abdallah BM; Ditzel N; Mahmood A; Isa A; Traustadottir GA; Schilling AF; Ruiz-Hidalgo MJ; Laborda J; Amling M; Kassem M
J Bone Miner Res; 2011 Jul; 26(7):1457-71. PubMed ID: 21308776
[TBL] [Abstract][Full Text] [Related]
3. Positive regulation of osteogenesis by bile acid through FXR.
Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS
J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136
[TBL] [Abstract][Full Text] [Related]
4. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
[TBL] [Abstract][Full Text] [Related]
5. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone).
Sottile V; Seuwen K; Kneissel M
Calcif Tissue Int; 2004 Oct; 75(4):329-37. PubMed ID: 15549648
[TBL] [Abstract][Full Text] [Related]
6. Increased trabecular bone formation in mice lacking the growth factor midkine.
Neunaber C; Catala-Lehnen P; Beil FT; Marshall RP; Kanbach V; Baranowsky A; Lehmann W; Streichert T; Ignatius A; Muramatsu T; Schinke T; Amling M
J Bone Miner Res; 2010 Aug; 25(8):1724-35. PubMed ID: 20200993
[TBL] [Abstract][Full Text] [Related]
7. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
[TBL] [Abstract][Full Text] [Related]
8. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass.
Nakanishi R; Akiyama H; Kimura H; Otsuki B; Shimizu M; Tsuboyama T; Nakamura T
J Bone Miner Res; 2008 Feb; 23(2):271-7. PubMed ID: 17907918
[TBL] [Abstract][Full Text] [Related]
9. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency.
Schiltz C; Marty C; de Vernejoul MC; Geoffroy V
J Cell Biochem; 2008 Aug; 104(5):1803-17. PubMed ID: 18384129
[TBL] [Abstract][Full Text] [Related]
11. Osteoblast-targeted overexpression of TAZ increases bone mass in vivo.
Yang JY; Cho SW; An JH; Jung JY; Kim SW; Kim SY; Kim JE; Shin CS
PLoS One; 2013; 8(2):e56585. PubMed ID: 23441207
[TBL] [Abstract][Full Text] [Related]
12. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
13. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
Wang L; Liu S; Quarles LD; Spurney RF
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
[TBL] [Abstract][Full Text] [Related]
14. Schnurri-2 deficiency counteracts against bone loss induced by ovariectomy.
Nagao M; Saita Y; Hanyu R; Hemmi H; Notomi T; Hayata T; Nakamoto T; Nakashima K; Kaneko K; Kurosawa H; Ishii S; Ezura Y; Noda M
J Cell Physiol; 2011 Mar; 226(3):573-8. PubMed ID: 21069746
[TBL] [Abstract][Full Text] [Related]
15. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice.
Notini AJ; McManus JF; Moore A; Bouxsein M; Jimenez M; Chiu WS; Glatt V; Kream BE; Handelsman DJ; Morris HA; Zajac JD; Davey RA
J Bone Miner Res; 2007 Mar; 22(3):347-56. PubMed ID: 17147488
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.
Kim J; Xing W; Wergedal J; Chan JY; Mohan S
Physiol Genomics; 2010 Jan; 40(2):100-10. PubMed ID: 19887580
[TBL] [Abstract][Full Text] [Related]
17. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
[TBL] [Abstract][Full Text] [Related]
18. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation.
Koyama H; Nakade O; Takada Y; Kaku T; Lau KH
J Bone Miner Res; 2002 Jul; 17(7):1219-29. PubMed ID: 12096835
[TBL] [Abstract][Full Text] [Related]
19. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice.
Cao J; Venton L; Sakata T; Halloran BP
J Bone Miner Res; 2003 Feb; 18(2):270-7. PubMed ID: 12568404
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss.
Lee SK; Kalinowski JF; Jacquin C; Adams DJ; Gronowicz G; Lorenzo JA
J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
